ATE57474T1 - Ozonentkeimung von blut und blutprodukten. - Google Patents

Ozonentkeimung von blut und blutprodukten.

Info

Publication number
ATE57474T1
ATE57474T1 AT86302433T AT86302433T ATE57474T1 AT E57474 T1 ATE57474 T1 AT E57474T1 AT 86302433 T AT86302433 T AT 86302433T AT 86302433 T AT86302433 T AT 86302433T AT E57474 T1 ATE57474 T1 AT E57474T1
Authority
AT
Austria
Prior art keywords
blood
products
ozone
ozone sanitization
physiological
Prior art date
Application number
AT86302433T
Other languages
English (en)
Inventor
Yuan Chung Zee
David C Bolton
Original Assignee
Medizone Int Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medizone Int Inc filed Critical Medizone Int Inc
Application granted granted Critical
Publication of ATE57474T1 publication Critical patent/ATE57474T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • A61L2/0094—Gaseous substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A61L2/20—Gaseous substances, e.g. vapours
    • A61L2/202—Ozone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1698—Blood oxygenators with or without heat-exchangers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/32—Oxygenators without membranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/02—Gases
    • A61M2202/0216—Ozone
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT86302433T 1985-04-03 1986-04-02 Ozonentkeimung von blut und blutprodukten. ATE57474T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/719,187 US4632980A (en) 1985-04-03 1985-04-03 Ozone decontamination of blood and blood products
EP86302433A EP0199479B1 (de) 1985-04-03 1986-04-02 Ozonentkeimung von Blut und Blutprodukten

Publications (1)

Publication Number Publication Date
ATE57474T1 true ATE57474T1 (de) 1990-11-15

Family

ID=24889094

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86302433T ATE57474T1 (de) 1985-04-03 1986-04-02 Ozonentkeimung von blut und blutprodukten.

Country Status (8)

Country Link
US (1) US4632980A (de)
EP (1) EP0199479B1 (de)
JP (1) JPS6221A (de)
AT (1) ATE57474T1 (de)
CA (1) CA1269935A (de)
DE (1) DE3674941D1 (de)
HK (1) HK45193A (de)
SG (1) SG17493G (de)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5281392A (en) * 1986-03-10 1994-01-25 Rubinstein Alan I Method for disinfecting red blood cells, blood products, and corneas
US5211912A (en) * 1986-08-01 1993-05-18 University Of Southern California Method for disinfecting red blood cells, blood products, and corneas
US5185371A (en) * 1986-03-10 1993-02-09 University Of Southern California Method for disinfecting red blood cells
US4971760A (en) * 1986-03-10 1990-11-20 University Of Southern California Novel method for disinfecting red blood cells, blood platelets, blood plasma, and optical corneas and sclerae
US4944920A (en) * 1986-08-01 1990-07-31 University Of Southern California Novel method to treat blood
DE3781279T2 (de) * 1986-08-01 1993-01-07 Alan I Rubinstein Verfahren zur behandlung von blut.
FR2603805A1 (fr) * 1986-09-16 1988-03-18 Transfusion Sanguine Assoc Rgl Procede d'inactivation par ozonolyse de micro-organismes contaminants presents dans des materiaux biologiques essentiellement proteiques, les produits obtenus et leurs applications biologiques et analytiques
US6303152B1 (en) * 1986-10-30 2001-10-16 Horst Kief Process for the production of substances that have been bactericidally treated and/or exhibit immune-modulatory activity, and the use thereof
ATE56363T1 (de) * 1986-10-30 1990-09-15 Horst Dr Med Kief Verfahren zur herstellung von keimabgetoeteten oder in ihrer virulenz abgeschwaechten substanzen sowie deren verwendung.
IL86417A (en) * 1987-05-22 1992-09-06 Armour Pharma Process for the inactivation of pathogens in biological or pharmaceutical material by mixing with aqueous solution containing a sugar(alcohol)and neutral salts as stabilizers
ATE120375T1 (de) * 1988-04-29 1995-04-15 Medizone Int Inc Vorrichtung für die gesteuerte generierung und verabreichung von ozon.
US5086076A (en) * 1988-06-24 1992-02-04 Stephen Herman Antiviral pharmaceutical compositions comprising a terpene ozonide
US5364879A (en) * 1988-06-24 1994-11-15 Cliveden Ltd. Medical uses of trioxolane and diperoxide compounds
US4983637A (en) * 1988-06-24 1991-01-08 Stephen Herman Method for treating viral infection of HIV
US5190977A (en) * 1988-06-24 1993-03-02 Stephen Herman Antiviral compositions
US5126376A (en) * 1988-06-24 1992-06-30 Stephen Herman Method for treating viral infection using topical administration
US5260342A (en) * 1988-06-24 1993-11-09 Stephen Herman Method for treating viral infection parenterally
US5270344A (en) * 1988-06-24 1993-12-14 Stephen Herman Method of treating a systemic disorder using trioxolane and diperoxide compounds
US5093326A (en) * 1989-06-19 1992-03-03 Stephen Herman Repellant compositions
AU637374B2 (en) * 1990-06-04 1993-05-27 Medizone International, Inc. Ozone decontamination of blood and blood products
GB9617611D0 (en) * 1996-08-22 1996-10-02 Vasogen Inc Treatment of autoimmune disease
US5980954A (en) 1992-02-07 1999-11-09 Vasogen Ireland Limited Treatment of autoimmune diseases
EP0680346B1 (de) * 1992-02-07 2002-07-03 Vasogen Inc. Verfahren zur erhöhung den stickoxidkonzentration im blut
US6204058B1 (en) 1992-02-07 2001-03-20 Vasogen Ireland Limited Treatment of autoimmune diseases
US6669965B2 (en) 1992-02-07 2003-12-30 Vasogen Ireland Limited Method of treating atherosclerosis
US6696092B2 (en) 1992-02-07 2004-02-24 Vasogen Ireland Limited Endothelial lining effects and treatment of vasospastic disorders
US5591457A (en) * 1992-02-07 1997-01-07 Vasogen Inc Method of inhibiting the aggregation of blood platelets and stimulating the immune systems of a human
FR2692486A1 (fr) * 1992-06-23 1993-12-24 Abdelmassih Zaki George Procédé et dispositif de stérilisation du sang des malades du SIDA ou d'une autre maladie bactérienne, parasitaire ou virale du sang.
EP0653945A1 (de) * 1992-07-31 1995-05-24 WAINWRIGHT, Basil, E. Vorrichtung und verfahren zum inaktivieren des menschlichen immundefizienzvirus
FR2694886A1 (fr) * 1992-08-06 1994-02-25 Zaki George Procédé et dispositif pour stériliser le sang des malades du sida, de la malaria ou d'une autre maladie bactérienne, parasitaire ou virale du sang.
DE4340730C2 (de) * 1993-12-01 1995-10-05 Waltraud Kockerols Verbindungssystem für die hyperbare Ozontherapie an einem Patienten
GB9502347D0 (en) * 1995-02-07 1995-03-29 Ca Nat Research Council Method and apparatus for inactivation of viruses in body fluids
US5540898A (en) * 1995-05-26 1996-07-30 Vasogen Inc. Ozone generator with in-line ozone sensor
US5741894A (en) * 1995-09-22 1998-04-21 Baxter International, Inc. Preparation of pharmaceutical grade hemoglobins by heat treatment in partially oxygenated form
WO1998009513A1 (en) * 1996-09-06 1998-03-12 Lifetech Corporation Method and apparatus for the sterilization of biological substrates
AU4393497A (en) * 1996-10-09 1998-05-05 Lifetech Corporation Method for the sterilization of biological materials
WO1998024456A1 (en) 1996-12-03 1998-06-11 Lisa Marlene Jeffreys Smith Reactive oxygen intermediates containing compounds effective in inducing cell differentiation of malignant cells such as leukemia
US20060003447A1 (en) * 2003-12-30 2006-01-05 Richard Fike Dry powder cells and cell culture reagents and methods of production thereof
US6627426B2 (en) 1997-02-14 2003-09-30 Invitrogen Corporation Methods for reducing adventitious agents and toxins and cell culture reagents produced thereby
US6383810B2 (en) * 1997-02-14 2002-05-07 Invitrogen Corporation Dry powder cells and cell culture reagents and methods of production thereof
US20040022666A1 (en) * 1998-06-30 2004-02-05 Invitrogen Corporation Methods for reducing adventitious agents and toxins and cell culture reagents produced thereby
EP2172227A3 (de) * 1998-06-30 2011-01-19 Life Technologies Corporation Verfahren zur Reduzierung von schädlichen Stoffen oder Toxinen in einer Probe und dadurch produzierte Zellkulturreagenzien
AU2001261627A1 (en) * 2000-05-24 2001-12-03 Medizone International, Inc. Method and apparatus for ozone decontamination of biological liquids
NZ526173A (en) * 2000-11-06 2005-03-24 Invitrogen Corp Dry powder cells and cell culture reagents and methods of production thereof
US20030228564A1 (en) * 2001-05-30 2003-12-11 Edrich Richard Alan Nitric oxide in a pathogen inactivation process
WO2003020103A2 (en) * 2001-09-04 2003-03-13 Amit Technology Science & Medicine Ltd. Method of and device for therapeutic illumination of internal organs and tissues
US20030073945A1 (en) * 2001-10-17 2003-04-17 Liang-Kuang Diang Ozone hemodiafiltration device
US20030118473A1 (en) * 2001-11-02 2003-06-26 Sunnen Gerard V. Method and apparatus for ozone decontamination of biological liquids
EP2251417A1 (de) * 2001-11-30 2010-11-17 Life Technologies Corporation Trockenpulver Zellkulturmedien mit Lipiden und Verfahren dessen Herstellung
US7118852B2 (en) * 2002-04-11 2006-10-10 Throwleigh Technologies, L.L.C. Methods and apparatus for decontaminating fluids
WO2003086479A1 (en) * 2002-04-12 2003-10-23 Throwleigh Technologies, L.L.C. Methods and apparatus for decontaminating fluids
JP3890044B2 (ja) 2003-02-18 2007-03-07 シャープ株式会社 活性化ガスが抗原性物質を失活させる性能の評価方法、その評価方法の評価試料として用いる処理済抗原性物質の作成装置
JP4662557B2 (ja) 2003-06-09 2011-03-30 レドックス−リアクティブ リエイジェンツ リミテッド ライアビリティー カンパニー 酸化還元反応による血漿タンパク質の結合特異性の改変方法
US20050189302A1 (en) * 2003-07-31 2005-09-01 Latino Joseph S. Viral inactivation using ozone
US7736494B2 (en) * 2003-07-31 2010-06-15 Acquisci, Inc. Ozone delivery system including a variable pitch gas-fluid contact device
US20100316730A1 (en) * 2003-07-31 2010-12-16 Latino Joseph S Treatment of cardiovascular diseases with ozone
US20100318014A1 (en) * 2003-07-31 2010-12-16 Latino Joseph S Treatment of acute ischemic brain stroke with ozone
US20100316727A1 (en) * 2003-07-31 2010-12-16 Latino Joseph S Treatment of inflammatory disorders with ozone
US20050051497A1 (en) * 2003-07-31 2005-03-10 Latino Joseph S. Viral inactivation using ozone
US7615030B2 (en) * 2003-10-06 2009-11-10 Active O, Llc Apparatus and method for administering a therapeutic agent into tissue
US8066659B2 (en) 2004-06-15 2011-11-29 Ceramatec, Inc. Apparatus and method for treating and dispensing a material into tissue
US8777889B2 (en) 2004-06-15 2014-07-15 Ceramatec, Inc. Apparatus and method for administering a therapeutic agent into tissue
US20060273045A1 (en) * 2005-06-03 2006-12-07 BAGLEY David Method of spinning water and oxygen for producing super-oxygenated and structured water
US8353906B2 (en) * 2005-08-01 2013-01-15 Ceramatec, Inc. Electrochemical probe and method for in situ treatment of a tissue
EP1779891A1 (de) * 2005-10-28 2007-05-02 Abdula Kurkayev Verfahren zum Aktivieren eines Photosensibilisators
ITMI20131667A1 (it) * 2013-10-09 2015-04-10 Ind Paolo Gobbi Frattini Metodo per pre-trattare le cellule ematiche prima della separazione.
AU2017312194A1 (en) 2016-08-19 2019-04-04 Immunores-Therapeutics, LLC Gas treatment delivery systems and methods
WO2018035504A1 (en) 2016-08-19 2018-02-22 Lane Ronald Howard Gas treatment delivery systems and methods

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4183962A (en) * 1978-01-16 1980-01-15 Exxon Research & Engineering Co. Process for oxygenating blood by the utilization of liquid membranes
NZ203094A (en) * 1982-02-09 1986-04-11 Univ California Vaccines with ozone-treated microorganisms
US4581231A (en) * 1982-06-10 1986-04-08 The United States Of America As Represented By The Secretary Of Health And Human Services Inactivation of viruses containing essential lipids
US4540573A (en) * 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
DE3325568A1 (de) * 1983-07-15 1985-01-24 Erwin Sander Elektroapparatebau GmbH, 3162 Uetze Verfahren zur schonenden ozonbehandlung von fluessigkeiten, wie etwa fruchtsaefte, milch, fluessige milchprodukte, wein, oele, fluessige medikamente, blut und oder aehnliche produkte

Also Published As

Publication number Publication date
JPS6221A (ja) 1987-01-06
CA1269935A (en) 1990-06-05
JPH0471892B2 (de) 1992-11-16
DE3674941D1 (de) 1990-11-22
HK45193A (en) 1993-05-14
EP0199479A2 (de) 1986-10-29
US4632980A (en) 1986-12-30
SG17493G (en) 1993-04-16
US4632980B1 (de) 1990-06-26
EP0199479A3 (en) 1987-08-26
EP0199479B1 (de) 1990-10-17

Similar Documents

Publication Publication Date Title
ATE57474T1 (de) Ozonentkeimung von blut und blutprodukten.
KR890011606A (ko) 항응고제
FI924975A (fi) Foerfarande foer framstaellning av trombin
DE3788984T2 (de) Verwendung von Prostaglandin-D2-aktiven-Substanzen zur Behandlung von Augen-Hypertension und von Glaukom.
DE69008664T2 (de) Bestrahlung von bluterzeugnissen.
FI946004A0 (fi) Lääketieteellisessä toimenpiteessä käytettävä trombiiniverifraktio
ATE74282T1 (de) Methode zur behandlung von plasma und dessen produkten.
ATE122885T1 (de) Mittel zur behandlung von herzerkrankungen.
DE3750934D1 (de) Behandlung von nicht-Akne-entzündlichen und -infektiösen Hautkrankheiten.
DE3781104D1 (de) Pasteurisierung von immunoglobulinloesungen.
DE3777861D1 (de) Behandlung von gasen.
FI882129A (fi) Preparat med antimikrobisk verkan.
DE3686108T2 (de) Verwendung von p-chlorophenoxyazetat von n,n-dimethylbiguanid zur behandlung von neuropathien und nervendegeneration.
DE3884895D1 (de) Verwendung von Bezafibrat zur Behandlung von Diabetes.
ATE25969T1 (de) 1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan zur verwendung bei der bekaempfung von krankheiten.
DE3674321D1 (de) Behandlung geschmeidiger gewebe.
DE3769497D1 (de) Mittel zur bekaempfung von phytopathogenen mikroben.
ES2059826T3 (es) Utilizacion de quimotripsina para inactivar el activador de precalicreina en productos sanguineos derivados de plasma humano o animal.
DE3668338D1 (de) Kontinuierliche behandlung von spannungslosem gewebe.
ATE74537T1 (de) Behandlung von gebrauchten antimonhalidkatalysatoren.
DE58901297D1 (de) Noremopamil, seine herstellung und verwendung.
DE3687895T2 (de) Arginin- und agmatinderivate zur behandlung von protozoen-infektionen.
DE3770742D1 (de) Behandlung von sichelzellanaemie.
DE3883754T2 (de) Mittel zur prophylaxe und behandlung von viralen infektionskrankheiten.
DE68906028D1 (de) Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom.

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee